S'abonner

IFN-? and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis - 06/06/19

Doi : 10.1016/j.jaci.2018.10.068 
Stéphanie Humblet-Baron, MD, PhD a, b, , Dean Franckaert, PhD a, b, , James Dooley, PhD a, b, Fatima Ailal, MD c, Aziz Bousfiha, MD c, Caroline Deswarte, MSc d, e, Carmen Oleaga-Quintas, MSc d, e, Jean-Laurent Casanova, MD, PhD d, e, f, g, h, Jacinta Bustamante, MD, PhD d, e, f, i, Adrian Liston, PhD a, b,
a VIB Center for Brain & Disease Research, Leuven, Belgium 
b KU Leuven–University of Leuven, Department of Microbiology and Immunology, Leuven, Belgium 
c Clinical Immunology Unit, Casablanca Children's Hospital, Ibn Rochd Laboratoire LICIA d'Immunologie Clinique, Inflammation et Allergie, Medical School, Hassan II University, Casablanca, Morocco 
d Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Imagine Institute, Necker Hospital for Sick Children, Paris, France 
e Paris Descartes University, Paris, France 
f St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY 
g Howard Hughes Medical Institute, New York, NY 
h Pediatric Hematology-Immunology Unit, Assistance Publique-Hôpitaux de Paris AP-HP, Necker Hospital for Sick Children, Paris, France 
i Center for the Study of Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris AP-HP, Necker Hospital for Sick Children, Paris, France 

Corresponding author: Adrian Liston, PhD, Autoimmune Genetics Laboratory, VIB, Leuven, Belgium, and the Department of Microbiology and Immunology, University of Leuven, Herestraat 49, 3000 Leuven, Belgium.Autoimmune Genetics LaboratoryVIB, Leuven, Belgium, and the Department of Microbiology and ImmunologyUniversity of LeuvenHerestraat 49Leuven3000Belgium

Abstract

Background

Inflammatory activation of CD8+ T cells can, when left unchecked, drive severe immunopathology. Hyperstimulation of CD8+ T cells through a broad set of triggering signals can precipitate hemophagocytic lymphohistiocytosis (HLH), a life-threatening systemic inflammatory disorder.

Objective

The mechanism linking CD8+ T-cell hyperactivation to pathology is controversial, with excessive production of IFN-γ and, more recently, excessive consumption of IL-2, which are proposed as competing hypotheses. We formally tested the proximal mechanistic events of each pathway in a mouse model of HLH.

Methods

In addition to reporting a complete autosomal recessive IFN-γ receptor 1–deficient patient with multiple aspects of HLH pathology, we used the mouse model of perforin (Prf1)KO mice infected with lymphocytic choriomeningitis virus to genetically eliminate either IFN-γ production or CD25 expression and assess the immunologic, hematologic, and physiologic disease measurement.

Results

We found a striking dichotomy between the mechanistic basis of the hematologic and inflammatory components of CD8+ T cell–mediated pathology. The hematologic features of HLH were completely dependent on IFN-γ production, with complete correction after loss of IFN-γ production without any role for CD8+ T cell–mediated IL-2 consumption. By contrast, the mechanistic contribution of the immunologic features was reversed, with no role for IFN-γ production but substantial correction after reduction of IL-2 consumption by hyperactivated CD8+ T cells. These results were complemented by the characterization of an IFN-γ receptor 1–deficient patients with HLH-like disease, in whom multiple aspects of HLH pathology were observed in the absence of IFN-γ signaling.

Conclusion

These results synthesize the competing mechanistic models of HLH pathology into a dichotomous pathogenesis driven through discrete pathways. A holistic model provides a new paradigm for understanding HLH and, more broadly, the consequences of CD8+ T-cell hyperactivation, thereby paving the way for clinical intervention based on the features of HLH in individual patients.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Key words : IFN-γ, CD25, CD8+ T-cell hyperactivation, hemophagocytic lymphohistiocytosis

Abbreviations used : AR, DKO, EBV-B cell, HLH, IFN-γR1, JAK, LCMV, NK, sCD25, STAT, Treg


Plan


 Supported by the VIB Grand Challenges, FWO, and IUAP (T-TIME). S.H-B. was supported by an FWO postdoctoral fellowship. The Laboratory of Human Genetics of Infectious Diseases is supported by grants from the St. Giles Foundation, the Jeffrey Modell Foundation, the Rockefeller University Center for Clinical and Translational Science, grant no. 8UL1TR000043 from the National Center for Research Resources and the National Center for Advancing Sciences (NCATS), the National Institutes of Health, the National Institute of Allergy and Infectious Diseases (grant no. 5R01AI089970-02), the Rockefeller University, the European Research Council (ERC), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID), and the French National Research Agency (ANR) under the “Investments for the future” program (grant no. ANR-10-IAHU-01 and ANR-GENMSMD (ANR-16-CE17-0005-01).
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2018  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 143 - N° 6

P. 2215 - juin 2019 Retour au numéro
Article précédent Article précédent
  • Cytokine-induced endogenous production of prostaglandin D2 is essential for human group 2 innate lymphoid cell activation
  • Jovana Maric, Avinash Ravindran, Luca Mazzurana, Aline Van Acker, Anna Rao, Efthymia Kokkinou, Maria Ekoff, Dominique Thomas, Alexander Fauland, Gunnar Nilsson, Craig E. Wheelock, Sven-Erik Dahlén, Nerea Ferreirós, Gerd Geisslinger, Danielle Friberg, Akos Heinemann, Viktoria Konya, Jenny Mjösberg
| Article suivant Article suivant
  • Sialic acid–binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies
  • Fanny Legrand, Yun Cao, Joshua B. Wechsler, Xiang Zhu, Nives Zimmermann, Shakuntala Rampertaap, Joseph Monsale, Kimberly Romito, Bradford A. Youngblood, Emily C. Brock, Michelle A. Makiya, Nenad Tomasevic, Christopher Bebbington, Irina Maric, Dean D. Metcalfe, Bruce S. Bochner, Amy D. Klion

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.